Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
iShares Microcap ETF
(NY:
IWC
)
163.37
+0.72 (+0.44%)
Streaming Delayed Price
Updated: 3:51 PM EDT, Apr 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iShares Microcap ETF
< Previous
1
2
3
4
5
Next >
Palladyne AI Subsidiary Wins US Navy Contract For Developing New Missiles — PDYN Stock Soars Pre-Market
↗
March 18, 2026
The company said that the Air-Launched Rapid Response Missile is expected to deliver nearly hypersonic speed and long range at a fraction of the cost of other hypersonic weapons.
Via
Stocktwits
Topics
Artificial Intelligence
Economy
Why Is GLSI Stock Rising Today?
↗
March 17, 2026
Greenwich LifeSciences said its Phase III breast cancer immunotherapy trial, involving 250 patients, showed a recurrence rate of under 1% per year.
Via
Stocktwits
Topics
Economy
Government
RILY Stock Rallies After-Hours – How Much Of Its Debt Is Reduced By Latest Senior Note Transactions?
↗
March 12, 2026
The company said upon closing of the final transaction with an institutional investor its outstanding debt will be reduced by approximately $37.9 million.
Via
Stocktwits
Topics
Earnings
FreightCar America Slumps 21% As Q4 Results And FY26 Disappoints Investors
↗
March 09, 2026
The company said its revenues in Q4 came at $125.6 million, lower than $137.7 million in the fourth quarter of 2024, despite railcar deliveries of 1,172 units compared to 1,019 units in the prior year...
Via
Stocktwits
INMB Stock Rises Pre-Market – What Did The FDA Say About Its Alzheimer’s Trial?
↗
February 12, 2026
Via
Stocktwits
Why Did MAXN Stock Surge 19% In Pre-Market Today?
↗
February 06, 2026
Via
Stocktwits
Why Is MAMO Stock Falling Pre-Market Today?
↗
February 03, 2026
Via
Stocktwits
ANTX Stock Records Biggest Ever Single Day Gain, Surges 500% Over Past Four Sessions – What Triggered This Smashing Rally?
↗
March 09, 2026
AN2 Therapeutics shares more than doubled in value on Monday after the company announced a private placement to raise about $40 million.
Via
Stocktwits
BNAI Stock Rockets 140% In 8 Days — Retail Traders Now Smell A Short Squeeze
↗
March 06, 2026
Recent expansion updates, a surge in retail interest, and a low stock float appear to be powering the stock.
Via
Stocktwits
Topics
Artificial Intelligence
Owlet Stock Is Down 26% After Hours – How Did The Company’s Q4 Results Fare?
↗
March 05, 2026
Owlet said that for the first quarter of 2026, it expects revenue in the range of $20 to $21 million. The forecast was significantly lower than Wall Street expectations of $26.2 million.
Via
Stocktwits
Palladyne AI CEO Touts Expanded Backlog, Deeper Defense Engagement After Q4 Beat Sends PDYN Stock Soaring
↗
March 05, 2026
Palladyne AI reported a loss of $0.04 per share, down from a loss of $1.75 per share during the same quarter a year ago, and better than Wall Street’s expectations of a loss of $0.14 per share.
Via
Stocktwits
Topics
Artificial Intelligence
Stocks
FARM Stock Sinks To 48-Year Lows – What Triggered The Collapse?
↗
March 04, 2026
The company announced an agreement to be acquired by Royal Cup Coffee & Tea in an all-cash deal valued at $1.29 per share.
Via
Stocktwits
Topics
Bankruptcy
Why Did CDXS Stock Jump 7% Today?
↗
March 04, 2026
The company tied up with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA using a proprietary ECO Synthesis platform.
Via
Stocktwits
BBAI Stock Slides 8% – Analyst Flags Soft Sales Estimate, Retail Expects A Further 50% Slump In Share Price
↗
March 03, 2026
Brokerages cut the stock’s price target after the company reported a 38% decline in fourth-quarter revenue.
Via
Stocktwits
Topics
Artificial Intelligence
TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint
↗
March 03, 2026
The company reported that its Phase 3 CYPRESS study of ampreloxetine in patients with hypotension failed to meet its primary endpoint.
Via
Stocktwits
Topics
Workforce
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial
↗
March 02, 2026
Aardvark Therapeutics shares saw brokerage downgrades after the company paused its Phase 3 trial to treat hyperphagia in patients with Prader-Willi syndrome.
Via
Stocktwits
KORE Stock Is Ripping Pre-Market Today After Company Agrees To A Deal To Take It Private
↗
February 27, 2026
KORE stated that Searchlight and Abry will acquire all shares of the company’s issued and outstanding common stock that they currently don’t own in an all-cash transaction valued at nearly $726...
Via
Stocktwits
Why Did NGNE Stock Surge 25% In Pre-Market Today?
↗
February 27, 2026
The company said that the U.S. Food and Drug Administration granted a key designation for its investigational gene therapy targeting Rett syndrome.
Via
Stocktwits
CIFR Stock Is Gaining Retail Attention After Earnings Despite Revenue Miss – Here’s What Investors Are Watching
↗
February 24, 2026
Cipher’s fourth-quarter revenue came in at $60 million, significantly below the consensus estimates of $85.7 million, according to Fiscal.ai data.
Via
Stocktwits
Topics
Bonds
Why Did PVLA Stock Surge 45% In Pre-Market Today?
↗
February 24, 2026
The biotech company reported statistically significant Phase 3 data for QTORIN gel.
Via
Stocktwits
ATOM Stock Is Falling Pre-Market Today After Atomera Announces Stock Offering At A Deep Discount
↗
February 23, 2026
The company announced on Monday that it has entered into a definitive agreement to sell 5 million shares of its common stock at an offering price of $5 per share.
Via
Stocktwits
Hycroft Mining Stock Is Rallying Today – What Is Driving Trader Sentiment?
↗
February 18, 2026
The company said that it has filed a third-party, independent Technical Report updating its Mineral Resource estimate with an effective date of January 21, 2026.
Via
Stocktwits
Why Is Cineverse Stock Rising Despite Missing Q3 Revenue and Earnings Estimates?
↗
February 17, 2026
The company said it expects $115 million to $120 million in revenue for fiscal year 2027, however analysts on average were expecting the revenue of $85.23 million, as per data from fiscal.ai.
Via
Stocktwits
CNVS Stock Surged 20% Today, Breaching 100-DMA For First Time Since August – Here’s What Triggered The Rally
↗
February 13, 2026
The company announced the acquisition of ad-tech firm IndiCue for up to $40 million in total consideration.
Via
Stocktwits
Topics
Economy
BURU Stock Set To Open At Record Low After Pricing Of Public Offering – Retail Signals Further Downside
↗
February 13, 2026
The company announced pricing for a $12 million public offering at an 8% discount to Thursday’s close.
Via
Stocktwits
MCRB Stock Declines As Seres Therapeutics Pauses SER-155 Phase 2 Study And Shrinks Headcount By 30%
↗
February 12, 2026
The company said that it will continue to seek funding for the SER-155 Phase 2 study.
Via
Stocktwits
Why Is QNCX Stock Up 60% Pre-Market After A Near-Total Wipeout?
↗
February 10, 2026
The company announced that it has appointed LifeSci Capital as its exclusive financial advisor to support a restructuring effort and review strategic alternatives.
Via
Stocktwits
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge
↗
February 09, 2026
The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration.
Via
Stocktwits
Why Did PDYN Stock Pop Over 10% In Pre-Market Today?
↗
February 03, 2026
The company signed an agreement with a major U.S. defense prime contractor to supply a subsystem that supports missile propulsion.
Via
Stocktwits
Topics
Artificial Intelligence
Why Did AQST Stock Jump 35% Today?
↗
February 02, 2026
The company received a Complete Response Letter from the U.S. Food and Drug Administration for its New Drug Application seeking approval of Anaphylm, a sublingual film to treat severe Type I allergic...
Via
Stocktwits
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
